Whether you are looking for a translational research partner, off-the-shelf cell line research tools, custom generation of precision functional genomics tools, molecular reference standards or you wish to access the post-genomic drug discovery toolbox, we can help. Click below to explore how Horizon can impact the application areas that are important to you.
Advances in DNA sequencing have allowed the genomes of nearly 200 species to be determined, unlocking the possibility to define and understand genetic diversity the molecular basis of disease, manipulate genomes and to identify novel personalized medicines targeted to specific patient populations
Genomic and proteomic science has advanced tremendously over the past decade, and have led to the development of “targeted” therapeutics and companion diagnostics, that leverage knowledge of an individual’s genetic makeup to create a more personalized approach to healthcare.
To fulfill the increasing demand for recombinant protein therapeutics, hundreds of millions of dollars have been invested by drug manufacturers and CMOs to develop the infrastructure required for culturing these cells in thousand liter scale-up.
Horizon Diagnostics, a business unit of Horizon Discovery Group plc, is a leading provider of genetically defined, human genomic reference standards, including FFPE cell line sections and purified DNA. These standards offer a sustainable source of reference